Biopharmaceutical profiling of anti-infective sanggenons from Morus alba root bark for inhalation administration
Mulberry Diels-Alder-type adducts (MDAAs), isolated from Morus alba root bark, exhibit dual activity against viral and bacterial pathogens but show sobering efficacy following oral administration. Inhalation administration may overcome issues with oral bioavailability and improve efficacy for the tr...
Saved in:
| Main Authors: | Jacqueline Schwarzinger, Sigrid Adelsberger, Karin Ortmayr, Sarah Luise Stellnberger, Ammar Tahir, Gabriela Hädrich, Verena Pichler, Judith M. Rollinger, Ulrike Grienke, Lea Ann Dailey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | International Journal of Pharmaceutics: X |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590156724000446 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hydromethanolic extracts of Morus alba L. (Mulberry) young and ripe fruit induces apoptosis in lung carcinoma cells (A549)
by: Payal Sargara, et al.
Published: (2025-01-01) -
An In-Depth Examination of Phytochemicals and Medicinal Uses on <i>Morus alba</i>
by: Roshan Kumar Dubey, et al.
Published: (2024-12-01) -
Therapeutic effect of Morus alba leaf extract and chlorogenic acid on inhibiting the progression of kidney disease
by: Ahmad Fauzi, et al.
Published: (2024-12-01) -
What are biopharmaceuticals?
by: Abhay H. Pande, et al.
Published: (2025-01-01) -
Advances in biopharmaceutical products for hemophilia
by: Junzheng Wu, et al.
Published: (2024-12-01)